AEON Biopharma (AEON) Operating Leases (2022 - 2026)
AEON Biopharma (AEON) posted Operating Leases of $893000.0 for Q4 2025, down 6.69% sequentially from $957000.0 in Q3 2025, and down 22.01% YoY from $1.1 million in Q4 2024.
AEON Biopharma (AEON) Operating Leases (2022 - 2026) Analysis & Trends
AEON Biopharma has reported Operating Leases for 4 years, with the latest figure at $893000.0 in Q4 2025.
- Quarterly Operating Leases fell 22.01% year-over-year to $893000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $893000.0 (down 22.01% YoY) and the FY2025 annual result came in at $893000.0, down 22.01% from the prior year.
- Operating Leases slipped to $893000.0 in Q4 2025 per AEON's latest filing, from $957000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.3 million in Q2 2024 and troughed at $52000.0 in Q3 2023.
- A 4-year average of $873111.1 and a median of $1.0 million in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases jumped 2215.38% in 2024, then dropped 22.01% in 2025.
- Over 4 years, Operating Leases stood at $242000.0 in 2022, then slumped by 78.51% to $52000.0 in 2023, then surged by 2101.92% to $1.1 million in 2024, then declined by 22.01% to $893000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $893000.0, $957000.0, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | AEON Biopharma | 9.66 Mn | 6.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 757,000.00 |
| Dec 31, 2025 | 893,000.00 |
| Sep 30, 2025 | 957,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Sep 30, 2023 | 52,000.00 |
| Dec 31, 2022 | 242,000.00 |